OKUR
Financials
- Market Capitalization 170.47 M
- Employee 45
- Founded 2011
- CEO N/A
- Website www.onkuretherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00JVRSRC1
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3302 |  QTTB Q32 Bio Inc. - Common Stock | 18.46 USD | -13.66% | +37.15% | +43.77% | +783.25% | 313.02 M USD | ||
| 3339 |  AMRN Amarin Corporation plc - American Depositary Shares, each repre | 14.37 USD | -2.24% | -7.23% | -6.69% | -7.65% | 301.33 M USD | ||
| 3768 |  CNTN Canton Strategic Holdings, Inc. - Common Stock | 2.30 USD | +1.32% | -6.50% | -29.88% | -51.58% | 160.55 M USD | ||
| 3952 |  PLYX Polaryx Therapeutics, Inc. - Common Stock | 2.26 USD | +2.73% | -12.40% | -2.59% | -94.98% | 107.00 M USD |
Frequently asked questions about OnKure Therapeutics, Inc. - Class A Common Stock
What is the OnKure Therapeutics, Inc. - Class A Common Stock stock price today?
The current price of OnKure Therapeutics, Inc. - Class A Common Stock (OKUR) is 4.22. Over the past 24 hours, the stock has changed by +2.68%. Follow the OKUR chart for real-time price dynamics.
What is the stock ticker of OnKure Therapeutics, Inc. - Class A Common Stock?
OnKure Therapeutics, Inc. - Class A Common Stock trades under the ticker OKUR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is OnKure Therapeutics, Inc. - Class A Common Stock stock going up?
OKUR has changed by -2.54% over the last week, +0.24% over the last month, and +72.24% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was OnKure Therapeutics, Inc. - Class A Common Stock net income for the last quarter?
OnKure Therapeutics, Inc. - Class A Common Stock reported net income of -15.16 M for the last quarter. The previous quarter showed -13.5 M, which means net income changed by -12.25%.
How many employees does OnKure Therapeutics, Inc. - Class A Common Stock have?
As of the latest available data, OnKure Therapeutics, Inc. - Class A Common Stock has 45 employees. Workforce size can provide additional context about the company's scale and operations.
What is OnKure Therapeutics, Inc. - Class A Common Stock EBITDA?
OnKure Therapeutics, Inc. - Class A Common Stock EBITDA is -15.05 M, and its EBITDA margin is -3 286.68%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy OnKure Therapeutics, Inc. - Class A Common Stock stock?
You can buy OnKure Therapeutics, Inc. - Class A Common Stock (OKUR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in OnKure Therapeutics, Inc. - Class A Common Stock stock?
Investing in OnKure Therapeutics, Inc. - Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the OKUR chart and related analysis on metatrader.com as part of your research.